Published

SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Hepatology
Date: 2026-04-30
Source: OpenAlex
DOI: 10.1016/s0168-8278(26)01861-1
PubMed: Unavailable

Authors

Anna Signor Martina Colognesi Giovanna Finzi Daniela Gabbia Andrea Mattarei Stefano Comai Gianfranco Pasut Franco Folli Paolo Manfredi Sara De Martin

Watch author

Topics and keywords

psilocybin Chronic Pain Pharmacology Receptor Pharmacology Animal Study Animal Study Antagonism Pharmacology Psilocybin Medicine Receptor Chemistry Hepatic fibrosis Drug Antagonist Serotonin Antagonists Psychedelics and Drug Studies Cannabis and Cannabinoid Research Pain Management and Placebo Effect

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models2026-04-30

Related papers

Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depressionPharmacological Research · 2026-06-10 Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim testJournal of Psychopharmacology · 2026-06-22 Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-28 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28 Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-05-31